152 related articles for article (PubMed ID: 30159860)
21. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
22. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
Etxaniz O; Carrato C; de Aguirre I; Queralt C; Muñoz A; Ramirez JL; Rosell R; Villà S; Diaz R; Estival A; Teixidor P; Indacochea A; Ahjal S; Vilà L; Balañá C
J Neurooncol; 2017 Nov; 135(2):273-284. PubMed ID: 28884377
[TBL] [Abstract][Full Text] [Related]
23. IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.
Cheng P; Chen K; Zhang S; Mu KT; Liang S; Zhang Y
Front Endocrinol (Lausanne); 2021; 12():763349. PubMed ID: 34790172
[TBL] [Abstract][Full Text] [Related]
24. Ollier disease.
Silve C; Jüppner H
Orphanet J Rare Dis; 2006 Sep; 1():37. PubMed ID: 16995932
[TBL] [Abstract][Full Text] [Related]
25. Cancer surveillance in children with Ollier Disease and Maffucci Syndrome.
Diezi M; Zambelli PY; Superti-Furga A; Unger S; Renella R
Am J Med Genet A; 2021 Apr; 185(4):1338-1340. PubMed ID: 33433055
[No Abstract] [Full Text] [Related]
26. IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.
Darlix A; Deverdun J; Menjot de Champfleur N; Castan F; Zouaoui S; Rigau V; Fabbro M; Yordanova Y; Le Bars E; Bauchet L; Gozé C; Duffau H
J Neurooncol; 2017 May; 133(1):37-45. PubMed ID: 28434111
[TBL] [Abstract][Full Text] [Related]
27. T
Kinoshita M; Uchikoshi M; Sakai M; Kanemura Y; Kishima H; Nakanishi K
Magn Reson Med Sci; 2021 Mar; 20(1):119-123. PubMed ID: 32101817
[TBL] [Abstract][Full Text] [Related]
28. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
29. A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up.
Rajeswarie RT; Rao S; Nandeesh BN; Yasha TC; Santosh V
J Clin Pathol; 2018 Apr; 71(4):323-329. PubMed ID: 28801347
[TBL] [Abstract][Full Text] [Related]
30. "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.
Jain R; Johnson DR; Patel SH; Castillo M; Smits M; van den Bent MJ; Chi AS; Cahill DP
Neuro Oncol; 2020 Jul; 22(7):936-943. PubMed ID: 32064507
[TBL] [Abstract][Full Text] [Related]
31. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
[TBL] [Abstract][Full Text] [Related]
32. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Mazurowski MA; Clark K; Czarnek NM; Shamsesfandabadi P; Peters KB; Saha A
J Neurooncol; 2017 May; 133(1):27-35. PubMed ID: 28470431
[TBL] [Abstract][Full Text] [Related]
33. Tumor cell vanishing with radiological changes suggesting progression in IDH-mutated diffuse astrocytoma treated only with surgery.
Hernandez-Lain A; Hilario A; Sepulveda JM; Cantero D; Ramos A; Perez-Nuñez A
Clin Neuropathol; 2018; 37(5):217-220. PubMed ID: 30079885
[TBL] [Abstract][Full Text] [Related]
34. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
[TBL] [Abstract][Full Text] [Related]
35. Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic Astrocytoma.
Galldiks N; Brunn A; Fink GR; Langen KJ
Clin Nucl Med; 2019 Oct; 44(10):e581-e582. PubMed ID: 31348085
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic astrocytoma.
Grimm SA; Chamberlain MC
CNS Oncol; 2016 Jul; 5(3):145-57. PubMed ID: 27230974
[TBL] [Abstract][Full Text] [Related]
37. Update on the imaging features of the enchondromatosis syndromes.
Sharif B; Lindsay D; Saifuddin A
Skeletal Radiol; 2022 Apr; 51(4):747-762. PubMed ID: 34302201
[TBL] [Abstract][Full Text] [Related]
38. Maffucci syndrome: a genome-wide analysis using high resolution single nucleotide polymorphism and expression arrays on four cases.
Pansuriya TC; Oosting J; Verdegaal SH; Flanagan AM; Sciot R; Kindblom LG; Hogendoorn PC; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2011 Sep; 50(9):673-9. PubMed ID: 21584901
[TBL] [Abstract][Full Text] [Related]
39. Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.
Jafari-Khouzani K; Loebel F; Bogner W; Rapalino O; Gonzalez GR; Gerstner E; Chi AS; Batchelor TT; Rosen BR; Unkelbach J; Shih HA; Cahill DP; Andronesi OC
Neuro Oncol; 2016 Nov; 18(11):1569-1578. PubMed ID: 27382115
[TBL] [Abstract][Full Text] [Related]
40. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.
Kickingereder P; Sahm F; Radbruch A; Wick W; Heiland S; Deimling Av; Bendszus M; Wiestler B
Sci Rep; 2015 Nov; 5():16238. PubMed ID: 26538165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]